Harley, C.B., Futcher, A.B., and Greider, C.W. (1990). Telomeres shorten during ageing of human fibroblasts. Naturę 345,458-460.
Hayashi, N., and Cunha, G.R. (1991). Mesenchyme-induced changes in the neoplastic characteristics of the dunning prostatic adenocarcinoma. Cancer Res. 51,4924-4930.
Heise, C., Hermiston, T., Johnson, L., Brooks, G., Sampson-Johannes, A., Williams, A., Hawkins, L., and Kim, D. (2000). An adenovirus El A mutant that demonstrates potent and selective systemie anti-tumoral efficacy. Nat. Med. 6, 1134-1139.
Heo, J., Reid, T., Ruo, L., Breitbach, C.J., Rosę, S., Bloomston, M., Cho, M., Lim, H.Y., Chung, H.C., Kim, C.W., et al. (2013). Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat. Med.
Higuchi, H., Bronk, S.F., Bateman, A., Harrington, K., Vile, R.G., and Gores, G.J. (2000) Viral fusogenic membranę glycoprotein expression causes syncytia formation with bioenergetic celi death: Implications for gene therapy. Cancer Res. 60, 6396-6402.
Hiscott, J. (2007). Triggering the innate antiviral response through IRF-3 activation. J Biol. Chem. 282, 15325-15329.
Hiscott, J., Grandvaux, N., Sharma, S., Tenoever, B.R., Servant, M.J., and Lin, R. (2003). Convergence of the NF-kB and interferon signaling pathways in the regulation of antiviral defenseand apoptosis. Ann. N. Y. Acad. Sci. 1010, 237-248.
Hof&nann, M., Wu, Y.-J., Gerber, M., Berger-Rentsch, M., Heimrich, B., Schwemmle, M., and Zimmer, G. (2010). Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis vims M mutants lacking host shut-off activity. J. Gen. Virol. 91, 2782-2793.
Holzinger, D., Joms, C., Stertz, S., Boisson-Dupuis, S., Thimme, R., Weidmann, M., Casanova, J.-L., Haller, O., and Kochs, G. (2007). Induction of MxA gene expression by Influenza A virus reąuires type I or type III interferon signaling. J. Virol. 81, 7776-7785.
Homung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M et al. (2006) 5'-Triphosphate RNA is the ligand for RIG-I. Science 314, 994-997.